Moderna (MRNA) Reports Interim Data From Phase 1 Study of mRNA-2752 Triplet Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/7/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Moderna (MRNA) Issues Statement on IP
November 11, 2021 1:02 PM ESTModerna (NASDAQ: MRNA) has recognized the substantial role that the NIAID has played in helping to develop Modernas COVID-19 vaccine by including NIAID scientists as co-inventors on published patent applications where they have made inventive contributions.
Under U.S. patent law, there are strict rules for determining who should be listed as inventors on a patent. Just because someone is an inventor on one patent application relating to our COVID-19... More
Pfizer (PFE) Asks FDA to Amend EUA and Include Booster for Everyone 18+, Analyst Sees Good Chances for Winning Approval and Upgrades BioNTech (BNTX) to Buy
November 11, 2021 9:01 AM ESTYesterday, Germany recommended only the Covid-19 vaccine developed by Pfizer (NYSE: PFE) and BioNTech (NYSE: BNTX) for under the 30s as it causes fewer heart inflammations in younger people than the Moderna (NASDAQ: MRNA).
The committee also recommended pregnant women receive only the BioNTech/Pfizer vaccine.
In the meantime, two... More
